Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vartanov AR"'
Autor:
Hundal J; Internal Medicine, University of Connecticut, Farmington, USA., Vartanov AR; Internal Medicine, University of Connecticut, Farmington, USA., Huh K; Internal Medicine, University of Connecticut Health, Farmington, USA., Ballesteros E; Pathology, University of Connecticut Health, Farmington, USA., Forbes V; Hematology-Oncology, University of Connecticut, Farmington, USA.
Publikováno v:
Cureus [Cureus] 2022 Feb 26; Vol. 14 (2), pp. e22635. Date of Electronic Publication: 2022 Feb 26 (Print Publication: 2022).
Autor:
Vartanov AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Lampson BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Alyea EP; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Moslehi JJ; Department of Medicine, Cardio-Oncology Program, Vanderbilt University Medical Center, Nashville, Tennessee., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
HeartRhythm case reports [HeartRhythm Case Rep] 2021 Mar 19; Vol. 7 (6), pp. 391-394. Date of Electronic Publication: 2021 Mar 19 (Print Publication: 2021).
Autor:
Davids MS; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Kim HT; b Biostatistics and Computational Biology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Yu L; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., De Maeyer G; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., McDonough M; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Vartanov AR; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Langey R; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Fernandes SM; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Hellman JM; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Francoeur K; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Arnason J; c Department of Medical Oncology , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA., Jacobsen ED; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., LaCasce AS; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Fisher DC; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA., Brown JR; a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 May; Vol. 60 (5), pp. 1312-1315. Date of Electronic Publication: 2018 Oct 15.
Autor:
Wang L; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, Shalek AK; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA;, Lawrence M; Broad Institute, Cambridge, MA;, Ding R; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA;, Gaublomme JT; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA;, Pochet N; Broad Institute, Cambridge, MA;, Stojanov P; Broad Institute, Cambridge, MA;, Sougnez C; Broad Institute, Cambridge, MA;, Shukla SA; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, Stevenson KE; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;, Zhang W; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, Wong J; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, Sievers QL; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, MacDonald BT; F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA; Department of Neurology, Harvard Medical School, Boston, MA;, Vartanov AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, Goldstein NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, Neuberg D; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;, He X; F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA; Department of Neurology, Harvard Medical School, Boston, MA;, Lander E; Broad Institute, Cambridge, MA;, Hacohen N; Broad Institute, Cambridge, MA; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Massachusetts General Hospital, Boston MA; and., Regev A; Broad Institute, Cambridge, MA;, Getz G; Broad Institute, Cambridge, MA;, Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Park H; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA;, Wu CJ; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publikováno v:
Blood [Blood] 2014 Aug 14; Vol. 124 (7), pp. 1089-98. Date of Electronic Publication: 2014 Apr 28.
Autor:
Velez NF; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Karia PS; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Vartanov AR; Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts., Davids MS; Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts., Brown JR; Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts., Schmults CD; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA dermatology [JAMA Dermatol] 2014 Mar; Vol. 150 (3), pp. 280-7.
Autor:
Wang L; Cancer Vaccine Center and the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, DeLuca DS, Zhang L, Zhang W, Vartanov AR, Fernandes SM, Goldstein NR, Folco EG, Cibulskis K, Tesar B, Sievers QL, Shefler E, Gabriel S, Hacohen N, Reed R, Meyerson M, Golub TR, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ
Publikováno v:
The New England journal of medicine [N Engl J Med] 2011 Dec 29; Vol. 365 (26), pp. 2497-506. Date of Electronic Publication: 2011 Dec 12.